HS

HÉLÈNE SICARD

IP Innate Pharma: 9 patents #10 of 85Top 15%
Overall (All Time): #541,798 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
12084498 Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma Cecile Bonnafous, RENAUD BUFFET 2024-09-10
11999784 Treatment of peripheral T cell lymphoma Cecile Bonnafous, RENAUD BUFFET, Mathieu Blery 2024-06-04
11970535 Treatment with anti-KIR3DL2 agents Carine Paturel 2024-04-30
11858990 KIR3DL2 binding agents Laurent Gauthier, Simon Kollnberger, Benjamin Rossi, Carine Paturel, STÉPHANIE CORNEN +1 more 2024-01-02
11078275 Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma Cecile Bonnafous, RENAUD BUFFET 2021-08-03
10577419 KIR3DL2 binding agents Laurent Gauthier, Simon Kollnberger, Benjamin Rossi, Carine Paturel, STÉPHANIE CORNEN +1 more 2020-03-03
10344087 Treatment of peripheral T cell lymphoma Cecile Bonnafous, RENAUD BUFFET, Mathieu Blery 2019-07-09
10246510 KIR3DL2 binding agents Laurent Gauthier, Benjamin Rossi, Carine Paturel 2019-04-02
10174112 Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma Cecile Bonnafous, RENAUD BUFFET 2019-01-08